ChatGPT for low- and middle-income countries: a Greek gift?

Abstract

ChatGPT (OpenAI, San Francisco, CA, USA) has made headlines across all industries, with healthcare no exception. ChatGPT has demonstrated the ability to pass the US Medical Licensing Examination1 and has applications ranging from facilitation of clinical documentation2,3 to acting as a chatbot for patient concerns.4 The family of GPT models, which power ChatGPT, belongs to a wider family of AI models called large language models (LLMs). LLMs are trained on large volumes of data allowing them to manifest generalist intelligence, and unlike “specific AI” they are capable of performing tasks they have not been specifically trained for.

Topics & Concepts